Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma

P. B. Bethwaite, J Koreth, C. S. Herrington, J. O'D. McGee

    Research output: Contribution to journalArticlepeer-review

    60 Citations (Scopus)


    Allelotypic detection of loss of heterozygosity (LOH) has been used to identify putative tumour-suppressor genes. Loci on human chromosome 11q23 are frequently altered in malignant disease, and LOH has been reported at an anonymous D11S29 locus at 11q23 in a proportion of breast and ovarian cancers and malignant melanomas. Previous studies have reported a high frequency of LOH in cervical carcinoma mapping to 11q23. Using polymerase chain reaction techniques employing probes for a recently described polymorphic dinucleotide microsatellite within this locus, we have searched for LOH in 69 cases of invasive cervical carcinoma. Genomic material was microdissected from sections cut from archival paraffin-embedded material, using the patients' constitutional genotype as a control Sixty-two (90%) of the cases were informative, and LOH occurred in 25/62 (40%) of tumours. Loss of an arm or single chromosome 11 is a well-recognised event in cervical carcinoma, and by employing other microsatellite polymorphisms mapping to 11q13 and 11p11-p12 we excluded those cases with widespread allelic loss. By doing so, LOH at D11S29 was found in 16/53 (30%) of tumours. The findings suggest a putative tumour-suppressor gene on 11q involved in cervical carcinogenesis.

    Original languageEnglish
    Pages (from-to)814-818
    Number of pages5
    JournalBritish Journal of Cancer
    Issue number4
    Publication statusPublished - Apr 1995


    Dive into the research topics of 'Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma'. Together they form a unique fingerprint.

    Cite this